Key pathways revealed in rare thyroid cancer

Key pathways revealed in rare thyroid cancer


Play all audios:


Access through your institution Buy or subscribe Anaplastic thyroid carcinoma (ATC) is a rare form of undifferentiated thyroid cancer that is treatment-resistant and has high mortality. A


new study in _Thyroid_ identifies signalling pathways that have important roles in the function of ATC cancer stem cells. “To screen for important intracellular signalling pathways, we used


an siRNA library to selectively knock down 719 kinases [in cells derived from human ATCs] and observed sphere-forming abilities, which reflects cancer stem cell ability,” explains


corresponding author Norisato Mitsutake. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other


Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online


access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which


are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES ORIGINAL ARTICLE *


Shiraiwa, K. et al. The JAK/STAT3 and NF-κB signaling pathways regulate cancer stem cell properties in anaplastic thyroid cancer cells. _Thyroid_ https://doi.org/10.1089/thy.2018.0212 (2019)


Article  PubMed  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews Endocrinology http://www.nature.com/nrendo/ Shimona Starling Authors *


Shimona Starling View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Shimona Starling. RIGHTS AND PERMISSIONS Reprints


and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Starling, S. Key pathways revealed in rare thyroid cancer. _Nat Rev Endocrinol_ 15, 254–255 (2019).


https://doi.org/10.1038/s41574-019-0193-7 Download citation * Published: 13 March 2019 * Issue Date: May 2019 * DOI: https://doi.org/10.1038/s41574-019-0193-7 SHARE THIS ARTICLE Anyone you


share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the


Springer Nature SharedIt content-sharing initiative